SPX-101 Is A Novel ENaC-Targeted Therapeutic For The Treatment Of Cystic Fibrosis

Dr. Matthew Walker
Monday, June 12, 2017 - 5:00pm
PG CRL Rm 1, 2nd Fl, 686 Bay St., SickKids
Cystic Fibrosis Seminar